Celgene to Acquire Receptos, Advancing Leadership in Immune-Inflammatory Diseases
Go back to Celgene to Acquire Receptos, Advancing Leadership in Immune-Inflammatory Diseases| Celgene Corp. (NASDAQ: CELG) | Delayed: 108.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $108.24 | 52 Week High | $127.00 | |||
| Open | $7.85 | 52 Week Low | $93.05 | |||
| Day High | $108.24 | P/E | 32.12 | |||
| Day Low | $108.24 | EPS | $3.37 | |||
| Volume | 0 | |||||
| RECEPTOS (NASDAQ: RCPT) | Delayed: 231.96 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $231.96 | 52 Week High | $232.02 | |||
| Open | $1.13 | 52 Week Low | $46.94 | |||
| Day High | $231.96 | P/E | N/A | |||
| Day Low | $231.96 | EPS | $-2.12 | |||
| Volume | 31,500 | |||||
